Davis Polk partner Yasin Keshvargar was quoted in a Business Insider article discussing the life sciences IPO boom in 2020. Keshvargar noted that 2020 brought more capital markets opportunities for biotech companies working on COVID-19 therapies and vaccines. 

“A Big Year in Biotech was a Windfall for Top IPO lawyers Laser Focused on the Space,” Business Insider (December 22, 2020) (subscription required)

Copy link to share post